AMSTERDAM and LONDON, September 5,
2016 /PRNewswire/ --
Philips to highlight the Dream Family connected
therapy system, announcing its
extension with the introduction of BiPAP
autoSV and BiPAP AVAPS therapy
devices
Philips Respironics, a division of Royal Philips (NYSE: PHG,
AEX: PHIA), will showcase its portfolio of connected sleep and
respiratory solutions at the European Respiratory Society (ERS)
International Congress 2016 in London (September
3-7). At this year's event, Philips will feature its Dream
Family therapy system with the most comprehensive suite of
connectivity options, now available in Europe with BiPAP autoSV and BiPAP AVAPS
therapy devices.
At a time when an estimated more than 100 million people
worldwide[1] are suffering from OSA, a
serious condition that is treated with positive airway pressure
(PAP) therapy, the patient experience has become an important
factor in the future of sleep therapy and respiratory care.
Building upon 40 years of experience in research and innovation in
sleep, and more than 10 years of cloud-based data sharing
experience, Philips continues to demonstrate its dedication to
improving the patient experience with over 7 million patients
supported through its EncoreAnywhere compliance management system.
With fully-integrated, connected solutions and coaching tools for
patients, Philips is helping physicians and care providers to
better manage and improve the lives of patients.
"Philips Respironics has a long history of creating innovative
technologies that are clinically proven to improve adherence and
the overall patient experience," said Mark
D'Angelo, Sleep Business Leader of Philips. "Continuing to
build on the connectivity and usability of our solutions is an
important way for us to better address the needs of patients by
offering consistent support throughout their therapy, helping them
live better lives."
At this year's ERS International Congress, Philips will be
showcasing its growing portfolio of connected sleep and respiratory
therapy management solutions including:
- Dream Family: The Dream Family is an integrated therapy
solution that includes the DreamStation PAP device, DreamWear mask,
and DreamMapper patient engagement application. At ERS, Philips is
introducing BiPAP autoSV and BiPAP AVAPS DreamStation devices in
Europe for patients suffering from
complex sleep apnea, central sleep apnea, mixed apnea and/or
periodic breathing, as well as patients with chronic respiratory
insufficiencies. The Dream Family's people-centered design helps
patients to experience, comfortable and effective sleep therapy
while connecting them to their care teams for optimal therapy
management. Since its launch in October
2015, components of Philips' Dream Family has been
recognized for its unique design by a number of institutions,
including iF Design, Red Dot, Good Design Australia, and
Core77.
- EncoreAnywhere: As the world's most widely-used patient
compliance management system, EncoreAnywhere provides physicians
with insight and the necessary tools to enhance overall patient
care. The web-based platform offers physicians and care teams
real-time remote access to valuable patient data to foster
adherence to therapy and efficient patient management.
Driving discussion on core sleep and respiratory trends
and challenges
Philips executives and partners will participate in the
following workshops and symposiums during ERS 2016, providing
insight into sleep-disordered breathing and respiratory care:
Industry Practical Workshop:
- Sunday, September 4, 1:15 - 2:30 p.m., ExCel Center, North Hall, Room
G
- "Effective Dyspnea and Cough Management in the COPD Patient"
Hosted by Patrick B. Murphy, Oxted,
United Kingdom
- Monday, September 5, 1:15 - 2:30 p.m., ExCel Center, South Hall, Room
M
- "Innovation and Sleep" Hosted by Dr. David White, MD and Brady Reidner, PhD, Denver, CO
Co-Sponsored Symposium:
- Tuesday, September 6,
5:30 - 7:00 p.m., Room ICC, Capital
Suite 7
- "Home Non-Invasive Ventilation for COPD patients: New
perspectives from the HOT-HMV Trial" hosted by D. White, H.
Woehrle, P. Murphy, N. Hart, and M. Dreher.
To experience the entire portfolio of sleep and respiratory
products, visit Philips at booth B-07. For updates on Philips'
presence at ERS 2016, visit http://philips.to/2b2GIEr. For more
information on Philips' advanced solutions for sleep and
respiratory care and updates from the show, visit @PhilipsResp and
follow #breatheinlife.
[1] http://www.stopbang.ca/osa/prevalence.php
About Philips Respironics
Philips Respironics is a global leader in the sleep and
respiratory care markets, offering solutions in sleep apnea
management, oxygen therapy, noninvasive ventilation and respiratory
drug delivery. With more than 10 years of cloud-based data sharing
experience and analytics for more than 7 million patient lives,
Philips Respironics has a long history of leading new innovation in
both devices and informatics solutions to help patients sleep and
breathe better.
About Royal
Philips
Royal Philips (NYSE: PHG, AEX:
PHIA) is a leading health technology company focused on improving
people's health and enabling better outcomes across
the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to
deliver integrated solutions. The company is a leader in
diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as
in consumer health and home care. Headquartered in
the Netherlands, Philips' health
technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000
employees with sales and services in more than 100 countries. News
about Philips can be found at
http://www.philips.com/newscenter.
For further information, please contact:
Alicia Cafardi
Philips
alicia.cafardi@philips.com
+1-412-523-9616